These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 21924229)

  • 1. Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs.
    Rouger K; Larcher T; Dubreil L; Deschamps JY; Le Guiner C; Jouvion G; Delorme B; Lieubeau B; Carlus M; Fornasari B; Theret M; Orlando P; Ledevin M; Zuber C; Leroux I; Deleau S; Guigand L; Testault I; Le Rumeur E; Fiszman M; Chérel Y
    Am J Pathol; 2011 Nov; 179(5):2501-18. PubMed ID: 21924229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation.
    Robriquet F; Babarit C; Larcher T; Dubreil L; Ledevin M; Goubin H; Rouger K; Guével L
    BMC Musculoskelet Disord; 2016 May; 17():209. PubMed ID: 27170302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell Transplantation.
    Robriquet F; Lardenois A; Babarit C; Larcher T; Dubreil L; Leroux I; Zuber C; Ledevin M; Deschamps JY; Fromes Y; Cherel Y; Guevel L; Rouger K
    PLoS One; 2015; 10(5):e0123336. PubMed ID: 25955839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells.
    Lardenois A; Jagot S; Lagarrigue M; Guével B; Ledevin M; Larcher T; Dubreil L; Pineau C; Rouger K; Guével L
    Proteomics; 2016 Jul; 16(14):2028-42. PubMed ID: 27246553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal Muscle Regenerative Potential of Human MuStem Cells following Transplantation into Injured Mice Muscle.
    Lorant J; Saury C; Schleder C; Robriquet F; Lieubeau B; Négroni E; Leroux I; Chabrand L; Viau S; Babarit C; Ledevin M; Dubreil L; Hamel A; Magot A; Thorin C; Guevel L; Delorme B; Péréon Y; Butler-Browne G; Mouly V; Rouger K
    Mol Ther; 2018 Feb; 26(2):618-633. PubMed ID: 29221805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular Delivery of Allogeneic MuStem Cells in Dystrophic Dogs Requires Only Short-Term Immunosuppression to Avoid Host Immunity and Generate Clinical/Tissue Benefits.
    Lorant J; Larcher T; Jaulin N; Hedan B; Lardenois A; Leroux I; Dubreil L; Ledevin M; Goubin H; Moullec S; Deschamps JY; Thorin C; André C; Adjali O; Rouger K
    Cell Transplant; 2018 Jul; 27(7):1096-1110. PubMed ID: 29871519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dystrophin expression following the transplantation of normal muscle precursor cells protects mdx muscle from contraction-induced damage.
    Rousseau J; Dumont N; Lebel C; Quenneville SP; Côté CH; Frenette J; Tremblay JP
    Cell Transplant; 2010; 19(5):589-96. PubMed ID: 20650035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
    He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
    Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
    Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M
    Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models.
    Quenneville SP; Chapdelaine P; Skuk D; Paradis M; Goulet M; Rousseau J; Xiao X; Garcia L; Tremblay JP
    Mol Ther; 2007 Feb; 15(2):431-8. PubMed ID: 17235323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro.
    Vieira NM; Brandalise V; Zucconi E; Jazedje T; Secco M; Nunes VA; Strauss BE; Vainzof M; Zatz M
    Biol Cell; 2008 Apr; 100(4):231-41. PubMed ID: 17997718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells.
    Skuk D; Goulet M; Roy B; Chapdelaine P; Bouchard JP; Roy R; Dugré FJ; Sylvain M; Lachance JG; Deschênes L; Senay H; Tremblay JP
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):371-86. PubMed ID: 16691118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Satellite Cells in Muscular Dystrophy - Lost in Polarity.
    Chang NC; Chevalier FP; Rudnicki MA
    Trends Mol Med; 2016 Jun; 22(6):479-496. PubMed ID: 27161598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: Local or systemic?
    Kerkis I; Ambrosio CE; Kerkis A; Martins DS; Zucconi E; Fonseca SA; Cabral RM; Maranduba CM; Gaiad TP; Morini AC; Vieira NM; Brolio MP; Sant'Anna OA; Miglino MA; Zatz M
    J Transl Med; 2008 Jul; 6():35. PubMed ID: 18598348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression.
    Wang Z; Kuhr CS; Allen JM; Blankinship M; Gregorevic P; Chamberlain JS; Tapscott SJ; Storb R
    Mol Ther; 2007 Jun; 15(6):1160-6. PubMed ID: 17426713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy.
    Siemionow M; Cwykiel J; Heydemann A; Garcia J; Marchese E; Siemionow K; Szilagyi E
    Stem Cell Rev Rep; 2018 Jun; 14(3):370-384. PubMed ID: 29546607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model.
    Torrente Y; Camirand G; Pisati F; Belicchi M; Rossi B; Colombo F; El Fahime M; Caron NJ; Issekutz AC; Constantin G; Tremblay JP; Bresolin N
    J Cell Biol; 2003 Aug; 162(3):511-20. PubMed ID: 12885758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microdystrophin ameliorates muscular dystrophy in the canine model of duchenne muscular dystrophy.
    Shin JH; Pan X; Hakim CH; Yang HT; Yue Y; Zhang K; Terjung RL; Duan D
    Mol Ther; 2013 Apr; 21(4):750-7. PubMed ID: 23319056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy.
    Le Guiner C; Servais L; Montus M; Larcher T; Fraysse B; Moullec S; Allais M; François V; Dutilleul M; Malerba A; Koo T; Thibaut JL; Matot B; Devaux M; Le Duff J; Deschamps JY; Barthelemy I; Blot S; Testault I; Wahbi K; Ederhy S; Martin S; Veron P; Georger C; Athanasopoulos T; Masurier C; Mingozzi F; Carlier P; Gjata B; Hogrel JY; Adjali O; Mavilio F; Voit T; Moullier P; Dickson G
    Nat Commun; 2017 Jul; 8():16105. PubMed ID: 28742067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.